Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
about
Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells.Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infectionMorphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophagesReactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.Lentiviral delivery of short hairpin RNAsRNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference.Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.
P2860
Q33610280-0A371B8D-EA03-4AD8-B286-5BC8CBEB4BF2Q35241638-4E78B9E1-68EB-4C8A-93EC-7D3370EC1724Q35852460-8361F78B-7895-41A7-94E0-F67B61F668F7Q35911433-EF215A33-FC5B-4B59-91B8-B8216C1D5072Q35942658-E270A0B7-BD31-484D-B5C5-1769B1BEBD4FQ36055034-BD0583E6-D7C8-40A6-B5AC-11C071E84E77Q37331638-F1AF8DA2-7A45-430D-86B9-14D770457C92Q37354387-5DB6895B-FFF0-4B67-A2D5-AD6A4C6BC6E9Q37430557-9B3DCBA2-8D76-41D6-B079-12A692A783ADQ37678411-C369706F-27B6-4993-AF9D-0E497042A156Q40237024-C19E7924-6340-44F5-96D3-6E310BF0F128Q41159088-72F3DF8D-1657-46DF-B0B6-A2299FA48B6F
P2860
Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antiviral effects of human imm ...... ect neurotropic viral strains.
@ast
Antiviral effects of human imm ...... ect neurotropic viral strains.
@en
Antiviral effects of human imm ...... ect neurotropic viral strains.
@nl
type
label
Antiviral effects of human imm ...... ect neurotropic viral strains.
@ast
Antiviral effects of human imm ...... ect neurotropic viral strains.
@en
Antiviral effects of human imm ...... ect neurotropic viral strains.
@nl
prefLabel
Antiviral effects of human imm ...... ect neurotropic viral strains.
@ast
Antiviral effects of human imm ...... ect neurotropic viral strains.
@en
Antiviral effects of human imm ...... ect neurotropic viral strains.
@nl
P2860
P1433
P1476
Antiviral effects of human imm ...... ect neurotropic viral strains.
@en
P2093
Rajnish S Dave
Roger J Pomerantz
P2860
P304
13687-13696
P356
10.1128/JVI.78.24.13687-13696.2004
P407
P577
2004-12-01T00:00:00Z